BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 28441138)

  • 21. Oncolytic Virotherapy in Glioma Tumors.
    Rius-Rocabert S; García-Romero N; García A; Ayuso-Sacido A; Nistal-Villan E
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Virotherapy--cancer targeted pharmacology.
    Tedcastle A; Cawood R; Di Y; Fisher KD; Seymour LW
    Drug Discov Today; 2012 Mar; 17(5-6):215-20. PubMed ID: 22198165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Virus, Oncolytic Virus and Human Prostate Cancer.
    Liu GB; Zhao L; Zhang L; Zhao KN
    Curr Cancer Drug Targets; 2017; 17(6):522-533. PubMed ID: 27993115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncolytic virotherapy of breast cancer.
    Hartkopf AD; Fehm T; Wallwiener D; Lauer UM
    Gynecol Oncol; 2011 Oct; 123(1):164-71. PubMed ID: 21764108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical development of oncolytic viruses in China.
    Liang M
    Curr Pharm Biotechnol; 2012 Jul; 13(9):1852-7. PubMed ID: 21740357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncolytic Virotherapy and Microenvironment in Multiple Myeloma.
    Marchica V; Costa F; Donofrio G; Giuliani N
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33668361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The mechanisms of genetically modified vaccinia viruses for the treatment of cancer.
    Jefferson A; Cadet VE; Hielscher A
    Crit Rev Oncol Hematol; 2015 Sep; 95(3):407-16. PubMed ID: 25900073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Turning killer into cure -- the story of oncolytic herpes simplex viruses.
    Zhang SX
    Discov Med; 2015 Nov; 20(111):303-9. PubMed ID: 26645902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical development directions in oncolytic viral therapy.
    Eager RM; Nemunaitis J
    Cancer Gene Ther; 2011 May; 18(5):305-17. PubMed ID: 21436867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving antitumor efficacy via combinatorial regimens of oncolytic virotherapy.
    Zhang B; Cheng P
    Mol Cancer; 2020 Nov; 19(1):158. PubMed ID: 33172438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Virus combinations and chemotherapy for the treatment of human cancers.
    Kumar S; Gao L; Yeagy B; Reid T
    Curr Opin Mol Ther; 2008 Aug; 10(4):371-9. PubMed ID: 18683102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic efficacy with oncolytic virus therapeutics: clinical proof-of-concept and future directions.
    Liu TC; Kirn D
    Cancer Res; 2007 Jan; 67(2):429-32. PubMed ID: 17234747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent advances in oncolytic virus design.
    Hernández-Alcoceba R
    Clin Transl Oncol; 2011 Apr; 13(4):229-39. PubMed ID: 21493183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncolytic viruses for induction of anti-tumor immunity.
    Tong AW; Senzer N; Cerullo V; Templeton NS; Hemminki A; Nemunaitis J
    Curr Pharm Biotechnol; 2012 Jul; 13(9):1750-60. PubMed ID: 21740355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of oncolytic viruses for cancer therapy.
    Abd-Aziz N; Poh CL
    Transl Res; 2021 Nov; 237():98-123. PubMed ID: 33905949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Questing for an optimal, universal viral agent for oncolytic virotherapy.
    Paiva LR; Martins ML; Ferreira SC
    Phys Rev E Stat Nonlin Soft Matter Phys; 2011 Oct; 84(4 Pt 1):041918. PubMed ID: 22181186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolution of oncolytic viruses: novel strategies for cancer treatment.
    Atherton MJ; Lichty BD
    Immunotherapy; 2013 Nov; 5(11):1191-206. PubMed ID: 24188674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Naturally oncolytic viruses.
    Roberts MS; Lorence RM; Groene WS; Bamat MK
    Curr Opin Mol Ther; 2006 Aug; 8(4):314-21. PubMed ID: 16955694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. To Infection and Beyond: The Multi-Pronged Anti-Cancer Mechanisms of Oncolytic Viruses.
    Cassady KA; Haworth KB; Jackson J; Markert JM; Cripe TP
    Viruses; 2016 Feb; 8(2):. PubMed ID: 26861381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent advances in targeting cancer stem cells using oncolytic viruses.
    Zhang YN; Wang SB; Song SS; Hu PY; Zhou YC; Mou YP; Mou XZ
    Biotechnol Lett; 2020 Jun; 42(6):865-874. PubMed ID: 32166558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.